Literature DB >> 9488250

Enalaprilat improves gut perfusion in critically injured patients.

E H Kincaid1, P R Miller, J W Meredith, M C Chang.   

Abstract

Inadequate splanchnic perfusion, detected as a low gastric intramucosal pH (pHi), in the face of normal systemic perfusion predicts an increased risk for multiple organ failure after trauma. Although the exact etiology of this low pHi is unknown, angiotensin II is thought to be an important regulator of gut perfusion during and after resuscitation from shock. The purpose of this study is to determine whether enalaprilat, an angiotensin-converting enzyme inhibitor, improves gut perfusion in critically injured patients. To test this hypothesis, 18 trauma patients monitored with a nasogastric tonometer and a pulmonary artery catheter were enrolled in a prospective study. A single dose of enalaprilat, .625 mg, was given as an i.v. bolus or a 4 h infusion following systemic resuscitation. Pre- and postdrug tonometric and hemodynamic data, including cardiac index, mean arterial pressure, right ventricular end-diastolic volume index, systemic vascular resistance index, and oxygen transport variables were compared using the paired t test. Results demonstrate that pHi was significantly improved after 4 h (7.13 +/- .04 to 7.19 +/- .03, p = .03) and after 24 h compared with baseline (7.14 +/- .04 to 7.25 +/- .04, p = .04). Overall, pHi increased in 12 of 18 patients. No significant differences were observed in any of the studied hemodynamic or systemic perfusion variables including mean arterial pressure (92 +/- 4 to 87 +/- 4, p = .24) and oxygen delivery (669 +/- 33 to 675 +/- 32, p = .82). In examining the determinants of pHi, the intramucosal-arterial PCO2 difference was improved after enalaprilat administration (27 +/- 6 to 17 +/- 3 mmHg, p = .04) while no difference was observed in arterial bicarbonate (19.5 +/- .7 to 19.7 +/- .8, p = .90). Additionally, the change in pHi observed with enalaprilat correlated with predrug intramucosal-arterial PCO2 difference (r = .74, r2 = .55, p = .0005). These results demonstrate that enalaprilat improves gut perfusion as measured by gastric tonometry in critically injured patients, and that this effect appears to be independent of changes in systemic perfusion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9488250     DOI: 10.1097/00024382-199802000-00001

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  6 in total

1.  Renin-angiotensin system activation correlates with microvascular dysfunction in a prospective cohort study of clinical sepsis.

Authors:  Kevin C Doerschug; Angela S Delsing; Gregory A Schmidt; Alix Ashare
Journal:  Crit Care       Date:  2010-02-22       Impact factor: 9.097

2.  The role of the intestine in the pathophysiology and management of severe acute pancreatitis.

Authors:  R S Flint; J A Windsor
Journal:  HPB (Oxford)       Date:  2003       Impact factor: 3.647

3.  Effects of the angiotensin-converting enzyme inhibitor perindopril on endothelial injury and hemostasis in rabbit endotoxic shock.

Authors:  Eric Wiel; Qian Pu; Jérôme Leclerc; Delphine Corseaux; Régis Bordet; Niels Lund; Brigitte Jude; Benoît Vallet
Journal:  Intensive Care Med       Date:  2004-03-13       Impact factor: 17.440

Review 4.  Understanding gastrointestinal perfusion in critical care: so near, and yet so far.

Authors:  G Ackland; M P Grocott; M G Mythen
Journal:  Crit Care       Date:  2000-09-01       Impact factor: 9.097

Review 5.  Gastric tonometry guided therapy in critical care patients: a systematic review and meta-analysis.

Authors:  Xin Zhang; Wei Xuan; Ping Yin; Linlin Wang; Xiaodan Wu; Qingping Wu
Journal:  Crit Care       Date:  2015-01-27       Impact factor: 9.097

Review 6.  The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation.

Authors:  Md Mominur Rahman; Fahadul Islam; Md Harun -Or-Rashid; Abdullah Al Mamun; Md Saidur Rahaman; Md Mohaimenul Islam; Atkia Farzana Khan Meem; Popy Rani Sutradhar; Saikat Mitra; Anjuman Ara Mimi; Talha Bin Emran; Rinaldi Idroes; Trina Ekawati Tallei; Muniruddin Ahmed; Simona Cavalu
Journal:  Front Cell Infect Microbiol       Date:  2022-06-20       Impact factor: 6.073

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.